Literature DB >> 18406334

Osteoblastic cells: differentiation and trans-differentiation.

Moustapha Kassem1, Basem M Abdallah, Hamid Saeed.   

Abstract

The osteoblast is the bone forming cell and is derived from mesenchymal stem cells (MSC) present among the bone marrow stroma. MSC are capable of multi-lineage differentiation into mesoderm-type cells such as osteoblasts and adipocytes. Understanding the mechanisms underlying osteoblast differentiation from MSC is a central topic in bone biology that can provide insight into mechanisms of bone maintenance and also novel pharmacological targets to increase osteoblast differentiation and consequently bone formation.

Entities:  

Mesh：

Year:  2008        PMID： 18406334     DOI： 10.1016/j.abb.2008.03.028

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


  28 in total

1.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Authors:  Ulrich Lindner; Jan Kramer; Jürgen Rohwedel; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

Review 2.  The molecular mechanism behind bone remodelling: a review.

Authors:  Peter Proff; Piero Römer
Journal:  Clin Oral Investig       Date:  2009-03-25       Impact factor: 3.573

3.  Construction of Sox9 gene eukaryotic expression vector and its inductive effects on directed differentiation of bone marrow stromal cells into precartilaginous stem cells in rats.

Authors:  Weihua Hu; Fengjing Guo; Feng Li; Hui Huang; Weikai Zhang; Anmin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

4.  Longitudinal assessment of oxytocin efficacy on bone and bone marrow fat masses in a rabbit osteoporosis model through 3.0-T magnetic resonance spectroscopy and micro-CT.

Authors:  Y Qiu; J Yao; X Wu; B Zhou; H Shao; T Hua; Z Xiong; G Tang
Journal:  Osteoporos Int       Date:  2014-10-22       Impact factor: 4.507

5.  Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.

Authors:  Roberta Gioia; Cristina Panaroni; Roberta Besio; Giovanni Palladini; Giampaolo Merlini; Vincenzo Giansanti; Ivana A Scovassi; Simona Villani; Isabella Villa; Anna Villa; Paolo Vezzoni; Ruggero Tenni; Antonio Rossi; Joan C Marini; Antonella Forlino
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

Review 6.  [Pathophysiology of bone metabolism].

Authors:  F Jakob; L Seefried; R Ebert
Journal:  Internist (Berl)       Date:  2008-10       Impact factor: 0.743

Review 7.  Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis.

Authors:  Gregory A Clines
Journal:  Curr Opin Organ Transplant       Date:  2010-02       Impact factor: 2.640

8.  Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function.

Authors:  Xiaoxue Zhang; Diane R Dowd; Meika C Moore; Tanya A Kranenburg; Magda A Meester-Smoor; Ellen C Zwarthoff; Paul N MacDonald
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

9.  Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts.

Authors:  Hongyou Yu; Paul de Vos; Yijin Ren
Journal:  Angle Orthod       Date:  2011-01       Impact factor: 2.079

10.  Para-nonylphenol impairs osteogenic differentiation of rat bone marrow mesenchymal stem cells by influencing the osteoblasts mineralization.

Authors:  Mohammad Husein Abnosi; Malek Soleimani Mehranjani; Mohammad Ali Shariatzadeh; Leila Dehdehi
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.